Literature DB >> 19047083

Centromere-associated protein E: a motor that puts the brakes on the mitotic checkpoint.

Kenneth W Wood1, Penelope Chua, David Sutton, Jeffrey R Jackson.   

Abstract

Cell cycle checkpoints have long been recognized as important nodes for regulating cell proliferation and maintaining genomic integrity. These checkpoints are often altered in cancer and represent promising points for therapeutic intervention. Until recently, direct targeting of the mitotic checkpoint has been an untapped area for cancer drug discovery. Regulation of the mitotic checkpoint is complex, but many of the critical players have been identified and functionally characterized. A substantial number of these proteins can be localized to the kinetochore, a structure located at the centromeric region of each mitotic chromosome. The kinetochore mediates chromosome attachment to spindle microtubules and subsequent chromosome movement. The mitotic checkpoint monitors microtubule attachment and chromosome position on the mitotic spindle, inhibiting progression into anaphase until proper attachment and metaphase positioning is achieved. Centromere-associated protein E is a kinesin microtubule motor protein that plays an essential role in integrating the mechanics of microtubule-chromosome interactions with mitotic checkpoint signaling, and has emerged as a novel target for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047083     DOI: 10.1158/1078-0432.CCR-07-4443

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  19 in total

1.  Targeting a kinetochore-associated motor protein to kill cancer cells.

Authors:  Sarah A Wacker; Tarun M Kapoor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

Review 2.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

Review 3.  Targeting mitotic pathways for endocrine-related cancer therapeutics.

Authors:  Shivangi Agarwal; Dileep Varma
Journal:  Endocr Relat Cancer       Date:  2017-06-14       Impact factor: 5.678

Review 4.  Traffic control: regulation of kinesin motors.

Authors:  Kristen J Verhey; Jennetta W Hammond
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

Review 5.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

6.  Gamma-actin is involved in regulating centrosome function and mitotic progression in cancer cells.

Authors:  Sela T Po'uha; Maria Kavallaris
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295.

Authors:  Xiangping Qian; Andrew McDonald; Han-Jie Zhou; Nicholas D Adams; Cynthia A Parrish; Kevin J Duffy; Duke M Fitch; Rosanna Tedesco; Luke W Ashcraft; Bing Yao; Hong Jiang; Jennifer K Huang; Melchor V Marin; Carrie E Aroyan; Jianchao Wang; Seyed Ahmed; Joelle L Burgess; Amita M Chaudhari; Carla A Donatelli; Michael G Darcy; Lance H Ridgers; Ken A Newlander; Stanley J Schmidt; Deping Chai; Mariela Colón; Michael N Zimmerman; Latesh Lad; Roman Sakowicz; Stephen Schauer; Lisa Belmont; Ramesh Baliga; Daniel W Pierce; Jeffrey T Finer; Zhengping Wang; Bradley P Morgan; David J Morgans; Kurt R Auger; Chiu-Mei Sung; Jeff D Carson; Lusong Luo; Erin D Hugger; Robert A Copeland; David Sutton; John D Elliott; Jeffrey R Jackson; Kenneth W Wood; Dashyant Dhanak; Gustave Bergnes; Steven D Knight
Journal:  ACS Med Chem Lett       Date:  2010-01-19       Impact factor: 4.345

8.  Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target.

Authors:  Naomi J Balamuth; Andrew Wood; Qun Wang; Jayanti Jagannathan; Patrick Mayes; Zhe Zhang; Zhongxue Chen; Eric Rappaport; Joshua Courtright; Bruce Pawel; Barbara Weber; Richard Wooster; Eric O Sekyere; Glenn M Marshall; John M Maris
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

9.  DawnRank: discovering personalized driver genes in cancer.

Authors:  Jack P Hou; Jian Ma
Journal:  Genome Med       Date:  2014-07-31       Impact factor: 11.117

10.  Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition.

Authors:  Patrick A Mayes; Yan Y Degenhardt; Andrew Wood; Yana Toporovskya; Sharon J Diskin; Elizabeth Haglund; Christopher Moy; Richard Wooster; John M Maris
Journal:  Int J Cancer       Date:  2012-09-28       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.